ADVERTISEMENT

APhA Policy Manual

2018

Browse policies organized by category. Select a category to view the related policy statements.

12 categories • 30 policies

Advertising for Pharmacies

1 Policies
Depiction of Pharmacists in Public Media

APhA supports the development of guidelines or standards to enhance the depiction of the pharmacy profession in all public media.

Alcohol and Tobacco

1 Policies
Cigarette Sales in Pharmacies

  1. APhA recommends that tobacco products not be sold in pharmacies.
  2. APhA recommends that state and local pharmacist associations develop similar policy statements for their membership and increase their involvement in public educational programs regarding the health hazards of smoking.
  3. APhA recommends that individual pharmacists give particular attention to educating young people on the health hazards of smoking.
  4. APhA recommends that APhA-ASP develop projects aimed at educating young people on the health hazards of smoking, such as visiting schools and conducting health education programs.

Internships/Externships and Residencies

4 Policies
Pharmacy Practice-Based Research Networks

  1. APhA supports establishment of pharmacy practice-based research networks (PBRNs) to strengthen the evidence base in support of pharmacists’ patient care services.
  2. APhA encourages collaborations among stakeholders to determine the minimal infrastructure and resources needed to develop and implement local, regional, and nationwide networks for performing pharmacy practice-based research.
  3. APhA encourages pharmacy residency programs to actively participate in pharmacy practice-based research network (PBRNs).

Residency Training for Pharmacists

  1. APhA urges continued growth in the number of accredited pharmacy residency positions in all practice settings to better meet the future health care needs of the nation.
  2. APhA encourages active involvement of schools and colleges of pharmacy in the development and advancement of accredited pharmacy practice residency programs.
  3. APhA advocates for the allocation of adequate funding for accredited pharmacy residencies in all practice settings by governmental and other entities.
  4. APhA supports postgraduate training for new PharmD graduates.
  5. APhA supports accreditation of all pharmacy residency programs by federally recognized accrediting bodies to ensure quality training experiences.

Experiential Education

  1. APhA encourages the American Association of Colleges of Pharmacy (AACP), in collaboration with state boards of pharmacy, practitioner organizations, and other stakeholders, to develop national standardization among schools and colleges of pharmacy to improve the quality of student pharmacists’ experiential education. This standardization should be adopted by all schools and colleges of pharmacy and should include (a) a preceptor training program; (b) a model instrument for preceptors to evaluate student pharmacist performance in required pharmacy practice experiences; (c) a set of quality indicators for each required pharmacy practice experience; and (d) a report of quality indicator outcomes made available to all schools and colleges of pharmacy, faculty, and current and prospective students.
  2. APhA urges schools and colleges of pharmacy to dedicate adequate and equitable financial and human resources to experiential education.

Regulation of Student Pharmacists’ Practice Experience

  1. APhA encourages state boards of pharmacy to use the title “student pharmacist” to identify all students enrolled in their professional years of pharmacy education in an Accreditation Council for Pharmacy Education (ACPE) accredited program.
  2. APhA encourages state boards of pharmacy to permit a student pharmacist to perform the duties of a pharmacist within the applicable state’s scope of practice under a pharmacist’s supervision. Preceptors shall consider the experience and education of student pharmacists when providing pharmacy practice opportunities.

Licensure, Registration and Inspection of Facilities

2 Policies
Regulatory Compliance/Regulatory Burden

APhA supports measures that protect the patient, public, and employees from pharmacy conditions that pose a threat to health.

State Boards of Pharmacy/Inspections

  1. APhA supports inspections of pharmacies and peer review of pharmacists that promote high-quality pharmaceutical service and thereby serve to improve public health.
  2. APhA opposes the use of criminal investigative techniques during routine noncriminal pharmacy inspections.
  3. APhA supports regulation and inspection by boards of pharmacy of all facilities within a state at which drugs are dispensed, stored, or offered for sale in the same manner as pharmacies.

New Payment Systems

2 Policies
Product and Payment Systems

  1. APhA shall work with public and private sectors in developing timely educational processes which assist pharmacists to implement patient care, understand new payment systems, and apply emerging therapeutic advances to achieve desired patient outcomes.
  2. APhA supports payment systems that distinguish between compensation for the provision of pharmaceutical care and reimbursement for product distribution.
  3. APhA shall participate in the identification, development, and implementation of models for procurement and handling of therapeutic and diagnostic pharmaceutical products and devices which assure the continuous provision of pharmaceutical care by pharmacists.

Payment System Reform

  1. APhA must advocate reform of pharmacy payment systems to enhance the delivery of comprehensive medication-use management services.
  2. APhA must assume a leadership role, in cooperation with other pharmacy organizations, patients, other providers of health services, and third-party payers, in developing a payment system reform plan.
  3. APhA should encourage universal acceptance of all components of pharmaceutical care and their integration into pharmacy practice to support payment for services.

Other Employment Issues

1 Policies
Internet Access by Pharmacists

APhA supports ready access to Internet resources by pharmacists at their practice sites to facilitate delivery of patient care and to support professional development.

Other Public Health Issues

1 Policies
Re-Use of Devices Intended for “Single Use”

APhA opposes the reuse of devices intended for “single use” in the screening and management of patients, consistent with the Centers for Disease Control and Prevention (CDC) and Occupational Safety and Health Administration (OSHA) guidelines.

Pharmacy School Curriculum

2 Policies
Pharmacy Schools’ Curriculum and Contemporary Pharmacy Needs

  1. APhA supports adopting and maintaining continuous quality improvement processes at the national school/college level to identify differences between contemporary pharmacy practice and curriculum offerings, and to provide information and resources to encourage up-to-date curricula.
  2. APhA encourages pharmacists to cooperate with schools and colleges of pharmacy by participating as preceptors and permitting their practices to be used as experiential sites.

Regulation of Student Pharmacists’ Practice Experience

  1. APhA encourages state boards of pharmacy to use the title “student pharmacist” to identify all students enrolled in their professional years of pharmacy education in an Accreditation Council for Pharmacy Education (ACPE) accredited program.
  2. APhA encourages state boards of pharmacy to permit a student pharmacist to perform the duties of a pharmacist within the applicable state’s scope of practice under a pharmacist’s supervision. Preceptors shall consider the experience and education of student pharmacists when providing pharmacy practice opportunities.

Professional Fees

1 Policies
Compensation for Cognitive Services

  1. APhA recognizes that pharmacists provide patients cognitive services that may or may not be related to the dispensing or sale of a product.
  2. APhA demands payment parity for pharmacists providing patient care services that may or may not be related to the dispensing or sale of a product.

Student Pharmacist

1 Policies
Regulation of Student Pharmacists’ Practice Experience

  1. APhA encourages state boards of pharmacy to use the title “student pharmacist” to identify all students enrolled in their professional years of pharmacy education in an Accreditation Council for Pharmacy Education (ACPE) accredited program.
  2. APhA encourages state boards of pharmacy to permit a student pharmacist to perform the duties of a pharmacist within the applicable state’s scope of practice under a pharmacist’s supervision. Preceptors shall consider the experience and education of student pharmacists when providing pharmacy practice opportunities.

Emergency Contraception

APhA supports the voluntary involvement of pharmacists, in collaboration with other health care providers, in emergency contraceptive programs that include patient evaluation, patient education, and direct provision of emergency contraceptive medications.

Proper Handling and Disposal of Hazardous Pharmaceuticals and Associated Supplies and Materials

  1. APhA supports the proper handling and disposal of hazardous, pharmaceutical products and associated supplies and materials by health professionals and by patients to whom such products, supplies, and materials are provided.
  2. APhA supports involvement with representatives from other health professional organizations, industry, and government to develop recommendations for the proper handling and disposal of hazardous pharmaceuticals and associated supplies and materials.
  3. APhA supports the development of educational programs for health professionals and patients on the proper handling and disposal of hazardous pharmaceuticals and associated supplies and materials.

Re-Use of Devices Intended for “Single Use”

APhA opposes the reuse of devices intended for “single use” in the screening and management of patients, consistent with the Centers for Disease Control and Prevention (CDC) and Occupational Safety and Health Administration (OSHA) guidelines.

Pharmacy Practice-Based Research Networks

  1. APhA supports establishment of pharmacy practice-based research networks (PBRNs) to strengthen the evidence base in support of pharmacists’ patient care services.
  2. APhA encourages collaborations among stakeholders to determine the minimal infrastructure and resources needed to develop and implement local, regional, and nationwide networks for performing pharmacy practice-based research.
  3. APhA encourages pharmacy residency programs to actively participate in pharmacy practice-based research network (PBRNs).

Pharmacists’ Role in the Development and Implementation of Evidence-Based Clinical Guidelines

  1. APhA advocates direct involvement of pharmacists in the development, evaluation, and implementation of evidence-based clinical guidelines. Well-designed guidelines promote an interdisciplinary team approach to patient care that utilizes pharmacists' expertise in optimizing patient outcomes.
  2. APhA believes that evidence-based clinical guidelines should promote optimal patient care built on the best available scientific data. These guidelines should be developed using an interdisciplinary approach and should be evaluated regularly to ensure that they reflect current practice standards.
  3. APhA should promote educational programs, products, and services that facilitate the participation of pharmacists in the development, evaluation, and implementation of evidence-based practice guidelines in all practice settings.
  4. APhA advocates the use by pharmacists, in all practice settings, of evidence-based practice guidelines for pharmaceutical care built on the best scientific data to optimize patient outcomes. These guidelines should be developed using an interdisciplinary approach and should be evaluated regularly to ensure that they reflect current practice standards.

Pharmacy Practice-Based Research Networks

  1. APhA supports establishment of pharmacy practice-based research networks (PBRNs) to strengthen the evidence base in support of pharmacists’ patient care services.
  2. APhA encourages collaborations among stakeholders to determine the minimal infrastructure and resources needed to develop and implement local, regional, and nationwide networks for performing pharmacy practice-based research.
  3. APhA encourages pharmacy residency programs to actively participate in pharmacy practice-based research network (PBRNs).

Re-Use of Devices Intended for “Single Use”

APhA opposes the reuse of devices intended for “single use” in the screening and management of patients, consistent with the Centers for Disease Control and Prevention (CDC) and Occupational Safety and Health Administration (OSHA) guidelines.

Regulatory Compliance/Regulatory Burden

APhA supports measures that protect the patient, public, and employees from pharmacy conditions that pose a threat to health.

Emergency Contraception

APhA supports the voluntary involvement of pharmacists, in collaboration with other health care providers, in emergency contraceptive programs that include patient evaluation, patient education, and direct provision of emergency contraceptive medications.

Prescription Order Requirements

  1. APhA supports the use of technology to facilitate the transmission of prescription order information from the prescriber to the pharmacist of the patient’s choice at no additional cost to the pharmacy.
  2. APhA supports the use of technology where appropriate standards for patient confidentiality and prescriber and pharmacist verification are established.
  3. APhA supports the transmission of complete prescriber information on or with the prescription order that enables the pharmacist to readily identify and facilitate communication with the prescriber.
  4. APhA supports the use of specific instructions with prescription orders. Use of potentially confusing terminology (e.g.,“as directed,” unclear use of Latin phrases, confusing abbreviations) should be avoided.
  5. APhA supports the inclusion of the diagnosis or indication for use for which the medication is ordered on or with the transmission of the prescription order by use of standard diagnosis codes or within the directions for use. APhA further supports the inclusion of patient-specific information on or with the prescription order where appropriate.
  6. APhA supports public education about the benefits and risks of technological advances in pharmacy practice.

Promotion of Pharmaceutical Care

  1. APhA should continue to promote to the public the concepts and benefits of pharmaceutical care, differentiating pharmaceutical care practice from other pharmacy services.
  2. APhA opposes the use of the term "pharmaceutical care" by any individual or entity unless the pharmaceutical care service provided by the individual or entity incorporates the concepts specified in the APhA Principles of Practice for Pharmaceutical Care.

Pharmacy Practice-Based Research Networks

  1. APhA supports establishment of pharmacy practice-based research networks (PBRNs) to strengthen the evidence base in support of pharmacists’ patient care services.
  2. APhA encourages collaborations among stakeholders to determine the minimal infrastructure and resources needed to develop and implement local, regional, and nationwide networks for performing pharmacy practice-based research.
  3. APhA encourages pharmacy residency programs to actively participate in pharmacy practice-based research network (PBRNs).

Advertisement
Advertisement